Home>Topics>Companies>Beckman Coulter

Beckman Coulter BEC

  1. All
  2. Commentary
  3. Headlines
    1. Alere's Health Management Divestiture Is Step in Right Direction

      Commentary

      Tue, 28 Oct 2014

      fell 1% on an organic basis due to lower pain management revenue from the toxicology business and lower sales of Beckman Coulter BNP tests in light of supply constraints. As expected, health information solutions revenue fell 7%, probably

    2. Lower Reimbursement and Product Recalls Weigh on Alere's 2Q Results

      Commentary

      Mon, 4 Aug 2014

      due to lower utilization, as well as product returns for the INR business and a second-quarter recall of certain Beckman Coulter Triage BNP Tests. The company captured strong growth in India and Africa, though this was partially offset by weak

    3. Danaher Offers Mixed Second-Quarter Results, but Announces an Acquisition as a Peace Offering

      Commentary

      Thu, 17 Jul 2014

      business. We think the company’s integration of Beckman Coulter is beginning to pay dividends by enhancing margins ..... Adding to its life science and diagnostics business, Beckman Coulter acquired Siemens’s Microbiology business for

    4. Siemens to sell microbiology unit to US-based Danaher

      Headlines

      Thu, 17 Jul 2014

      FRANKFURT, July 17 (Reuters) - German engineering group Siemens agreed to sell its clinical microbiology business to Beckman Coulter , a subsidiary of Danaher Corp, as part of a restructuring plan...

    5. J&J's $4.15 Billion Diagnostics Sale Slightly Improves Competitive Position

      Commentary

      Thu, 16 Jan 2014

      don't expect any changes to our fair value estimate. (As a reference point, Danaher acquired diagnostics company Beckman Coulter in 2011 for approximately 2 times sales.) We view the divestiture as slightly strengthening Johnson & Johnson's

    6. Danaher Delivers Strong Fourth-Quarter Earnings and Cash Flow

      Commentary

      Thu, 18 Apr 2013

      2011 in the life sciences also stands out as Danaher continues to drive operating improvements from recently acquired Beckman Coulter and AB Sciex. During 2012, Danaher generated $3 billion of free cash flow, a 25% improvement versus the prior

    7. Danaher's Third Quarter Below Expectations, Cash Flow Remains Strong

      Commentary

      Thu, 18 Oct 2012

      in the prior year, after accounting for charges related to the Beckman Coulter acquisition. Our primary concerns for the portfolio reside in the ..... operations is nearly $3.4 billion, driven by strong performance at Beckman Coulter .

    8. Core Revenue Growth Continues to Weaken for Danaher in First Quarter

      Commentary

      Thu, 19 Apr 2012

      think the firm needs a bit more time to drive synergies from Beckman and Esko Artwork. Additionally, the recently announced acquisition ..... onto core margin, but there is only one more quarter that Beckman will not be in the comparisons, and we think the firm may

    9. Internal Revenue Growth Slows in 4Q for Danaher; Beckman Making Strides

      Commentary

      Tue, 31 Jan 2012

      versus the prior year. The addition of Beckman Coulter helped lift revenue another 33%. Beckman 's integration is going well by management's ..... within the firm. The company also noted that Beckman 's working capital has yet to really feel

    10. Danaher Reports Solid 3Q

      Commentary

      Thu, 20 Oct 2011

      all of which are outside the Beckman Coulter integration. While nothing seems ..... quarter with recently acquired Beckman folded into the organization ..... Management conceded that core growth at Beckman was essentially flat and the outlook

    « Prev12345Next »
    Content Partners